Literature DB >> 19074163

Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis.

Y H Lee1, J H Woo, S J Choi, J D Ji, G G Song.   

Abstract

Programmed cell death 1 (PDCD1 or PD1) polymorphisms have been inconsistently reported to be associated with systemic lupus erythematosus (SLE). The aim of this study was to explore whether the PDCD1 polymorphisms confer a susceptibility to SLE and lupus nephritis (LN). We conducted a meta-analysis on the association of PDCD1 polymorphisms with SLE in overall and specific ethnic populations. A total of 15 separate comparisons were included in this meta-analysis consisting of nine Europeans, two Latin Americans, two Africans, one Asian and one unknown participant. In subgroup analysis, the PD1.3A allele was significantly associated with SLE in Latin Americans (OR = 3.073, 95% CI = 1.416-6.461, P = 0.003), but not in patients of European and African decent. The PD1.3A allele was a risk factor for LN in European descendants (OR = 2.207, 95% CI = 1.488-3.467, P < 0.001). The PD1.5C allele was a risk factor for SLE in Europeans (OR = 1.297, 95% CI = 1.024-1.643, P = 0.031). In conclusion, this meta-analysis demonstrated an association of the PD1.3A allele with LN in European and SLE in Latin-American populations. Furthermore, the PD1.5C allele was associated with SLE susceptibility in Europeans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19074163     DOI: 10.1177/0961203308093923

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  23 in total

1.  Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis.

Authors:  Paula S Ramos; Elisabeth E Brown; Robert P Kimberly; Carl D Langefeld
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 2.  Genetics of Sjögren's syndrome in the genome-wide association era.

Authors:  John A Ice; He Li; Indra Adrianto; Paul Chee Lin; Jennifer A Kelly; Courtney G Montgomery; Christopher J Lessard; Kathy L Moser
Journal:  J Autoimmun       Date:  2012-01-29       Impact factor: 7.094

Review 3.  PD-1 immunobiology in systemic lupus erythematosus.

Authors:  Colleen S Curran; Sarthak Gupta; Ignacio Sanz; Elad Sharon
Journal:  J Autoimmun       Date:  2018-11-03       Impact factor: 7.094

Review 4.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  K L Moser; J A Kelly; C J Lessard; J B Harley
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

5.  The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-03-18       Impact factor: 4.575

6.  Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.

Authors:  Sanjay S Shete; Maria E Suarez-Almazor; Noha Abdel-Wahab; Adi Diab; Robert K Yu; Andrew Futreal; Lindsey A Criswell; Jean H Tayar; Ramona Dadu; Vickie Shannon
Journal:  Cancer Immunol Immunother       Date:  2021-01-07       Impact factor: 6.968

Review 7.  Associations between SLC2A9 polymorphisms and gout susceptibility : A meta-analysis.

Authors:  Y H Lee; Y H Seo; J-H Kim; S J Choi; J D Ji; G G Song
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

Review 8.  T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Authors:  Eoin F McKinney; Kenneth Gc Smith
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

Review 9.  Association between BLK polymorphisms and susceptibility to SLE : A meta-analysis.

Authors:  G G Song; Y H Lee
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

10.  Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.

Authors:  M N Salem; H A Taha; M Abd El-Fattah El-Feqi; N N Eesa; R A Mohamed
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.